Neutrophil count for the identification of postmenopausal hypertensive women at increased cardiovascular risk

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 695-703

  Angeli, Fabio ^a   Angeli, Enrica ^b   Ambrosio, Giuseppe ^b   Mazzotta, Giovanni ^b   Reboldi, Gianpaolo ^b   Verdecchia, Paolo ^b  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; LEUKOCYTE COUNT; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; NEUTROPHIL COUNT; POSTMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SMOKING; SYSTOLIC BLOOD PRESSURE;

AGE FACTORS; CARDIOVASCULAR DISEASES; CREATININE; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; LEUKOCYTE COUNT; MIDDLE AGED; NEUTROPHILS; POSTMENOPAUSE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 77949902561     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d53df6     Document Type: Article

References (36)

1. Kannel WB, Wilson PW. Risk factors that attenuate the female coronary disease advantage. Arch Intern Med 1995;155: 57-61.
2. American Heart Association. Heart and stroke facts: 1995 statistical supplement. Dallas (TX): American Heart Association; 1994. p. 11.
3. Friedlander AH. The physiology, medical management and oral implications of menopause. JADA 2002;133:73-81.
4. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users: results from a national cohort. Arch Intern Med 1993; 153:73-79
5. Kritz-Silverstein D, Barrett-Connor E, Wingard DL. Hysterectomy, oophorectomy, and heart disease risk factors in older women. Am J Public Health 1997;87:676-680
6. Keller ET, Zhang J, Yao Z, Qi Y. The impact of chronic estrogen deprivation on immunologic parameters in the ovari-ectomized rhesus monkey (Macaca mulatta) model of menopause. J Reprod Immunol 2001;50:41-55.
7. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995;91:2844-2850
8. Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004; 172:1-6.
9. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schömig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996;94:1239-1246
10. 2 radicals during reperfusion after prolonged myocardial ischemia. Am J Physiol Heart Circ Physiol 2001;280:H2649-57.
11. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511.
12. Berliner S, Rogowski O, Rotstein R, Fusman R, Shapira I, Bornstein NM, et al. Activated polymorphonuclear leukocytes and monocytes in the peripheral blood of patients with isch-emic heart and brain conditions correspond to the presence of multiple risk factors for atherothrombosis. Cardiology 2000; 94:19-25.
13. Eriksson EE, Xie X, Werr J, Thoren P, Lindbom L. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins. FASEB J 2001; 15:1149-1157
14. Naruko T, Ueda M, Haze K, van der Wal AC, van der Loos CM, Itoh A, et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 2002;106:2894-2900
15. Manabe S, Okura T, Watanabe S, Higaki J. Association between carotid haemodynamics and inflammation in patients with essential hypertension. J Hum Hypertens 2005;19: 787-791
16. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension 1994;24:793-801.
17. Expert Committee on the Diagnosis and Classification of Diabetes Mllitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-20.
18. Verdecchia P, Angeli F, Reboldi G, Carluccio E, Benemio G, Gattobigio R, et al. Improved cardiovascular risk stratification by a simple ECG index in hypertension. Am J Hypertens 2003;16:646-652
19. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170
20. Cox DR. Regression models and life-tables. J R Stat Soc (B) 1972;34:187-220.
21. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187
22. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: a meta-analysis of prospective studies. JAMA 1998;279:1477-1482
23. Gillum R, Ingram D, Makuc D. White blood cell count, coronary heart disease, and death: the NHANES 1 Epidemi-ological Follow-up Study. Am Heart J 1993;128:855-863
24. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE. Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 1997;96:1102-1108
25. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol 2001;54:316-322
26. Lee CD, Folsom AR, Nieto FJ, Chambless LE, Shahar E, Wolfe DA. White blood cell count and incidence of coronary heart disease and ischemic stroke and mortality from cardiovascular disease in African-American and white men and women: atherosclerosis risk in communities study. Am J Epidemiol 2001;154:758-764
27. Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med 2005;165:500-508
28. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR. Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 2005;45:1638-1643
29. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 1999;103:401-406
30. Caulin-Glaser T, García-Cardena G, Sarrel P, Sessa WC, Bender JR. 17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization. Circ Res 1997;81:885-892
31. Gilligan DM, Badar DM, PanzaJA, Quyyumi AA, Canon RO 3rd. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994;90:786-791
32. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994;121:936-941
33. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994;91: 5212-5216
34. BinkoJ, Majewski H. 17B-Estradiol reduces vasoconstriction in endotheliumdenuded rat aortas through inducible NOS. AmJ Physiol 1998;274:853-859
35. Kolodgie FD, Jacob A, Wilson PS, Carlson GC, Farb A, Verma A, et al. Estradiol attenuates directed migration of vascular smooth muscle cells in vitro. AmJ Pathol 1996;148:969-976
36. Bhalla RC, Toth TK, Bhatty RA, Thompson LP, Sharma RV. Estrogen reduces proliferation and agonist-induced calcium increase in coronary artery smooth muscle cells. AmJ Physiol 1997;272:1996-2003.